Legis Daily

Brycen Gray and Ben Price COVID–19 Neurological Impact Act

USA117th CongressHR-5772| House 
| Updated: 10/29/2021
Anthony Gonzalez

Anthony Gonzalez

Republican Representative

Ohio

Cosponsors (11)
Tim Ryan (Democratic)Robin L. Kelly (Democratic)Tony Cárdenas (Democratic)Scott H. Peters (Democratic)David P. Joyce (Republican)Dean Phillips (Democratic)Peter Meijer (Republican)Adam Kinzinger (Republican)Josh Gottheimer (Democratic)Jaime Herrera Beutler (Republican)Susan Wild (Democratic)

Health Subcommittee, Science, Space, and Technology Committee, Energy and Commerce Committee, Research and Technology Subcommittee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Brycen Gray and Ben Price COVID-19 Neurological Impact Act This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection. Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses. In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 28, 2021
Introduced in House
Oct 28, 2021
Referred to the Subcommittee on Research and Technology.
Oct 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 29, 2021
Referred to the Subcommittee on Health.
  • October 28, 2021
    Introduced in House
  • October 28, 2021
    Referred to the Subcommittee on Research and Technology.
  • October 28, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • October 29, 2021
    Referred to the Subcommittee on Health.

Health

Cardiovascular and respiratory healthChild healthEmergency medical services and trauma careExecutive agency funding and structureExecutive Office of the PresidentHealth information and medical recordsInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsMental healthNeurological disordersResearch administration and funding

Brycen Gray and Ben Price COVID–19 Neurological Impact Act

USA117th CongressHR-5772| House 
| Updated: 10/29/2021
Brycen Gray and Ben Price COVID-19 Neurological Impact Act This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection. Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses. In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 28, 2021
Introduced in House
Oct 28, 2021
Referred to the Subcommittee on Research and Technology.
Oct 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 29, 2021
Referred to the Subcommittee on Health.
  • October 28, 2021
    Introduced in House
  • October 28, 2021
    Referred to the Subcommittee on Research and Technology.
  • October 28, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • October 29, 2021
    Referred to the Subcommittee on Health.
Anthony Gonzalez

Anthony Gonzalez

Republican Representative

Ohio

Cosponsors (11)
Tim Ryan (Democratic)Robin L. Kelly (Democratic)Tony Cárdenas (Democratic)Scott H. Peters (Democratic)David P. Joyce (Republican)Dean Phillips (Democratic)Peter Meijer (Republican)Adam Kinzinger (Republican)Josh Gottheimer (Democratic)Jaime Herrera Beutler (Republican)Susan Wild (Democratic)

Health Subcommittee, Science, Space, and Technology Committee, Energy and Commerce Committee, Research and Technology Subcommittee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthChild healthEmergency medical services and trauma careExecutive agency funding and structureExecutive Office of the PresidentHealth information and medical recordsInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsMental healthNeurological disordersResearch administration and funding